Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.
- Citation:
- Ann Oncol vol 34 (11) 1025-34
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- Not Funded
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 13
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J Taieb F A Sinicrope L Pederson S Lonardi S R Alberts T J George G Yothers E Van Cutsem L Saltz S Ogino R Kerr T Yoshino R M Goldberg T André P Laurent-Puig Q Shi
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- ACCENT, IDEA
- Phases:
- N/A
- Keywords:
- BRAF(V600E) mutation, MSI/dMMR, RAS mutation, adjuvant, stage III colon cancer, survival after relapse, time to recurrence